Alerts will be sent to your verified email
Verify Email
JUBLPHARMA
|
Jubilant Pharmova
|
Caplin Point Lab
|
Natco Pharma
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
7.82 % | 20.61 % | 13.06 % |
|
5yr Avg Net Profit Margin
|
6.45 % | 24.8 % | 23.09 % |
|
Price to Book
|
2.65 | 9.42 | 2.04 |
|
P/E
|
35.98 | 45.43 | 9.12 |
|
5yr Avg Cash Conversion Cycle
|
-39.98 Days | 79.85 Days | 10.54 Days |
|
5yr Average Interest Coverage Ratio
|
3.78 | 579.71 | 60.49 |
|
5yr Avg ROCE
|
8.15 % | 25.27 % | 16.05 % |
|
5yr Avg Operating Profit Margin
|
16.76 % | 30.87 % | 30.17 % |
|
5 yr average Debt to Equity
|
0.55 | 0.01 | 0.06 |
|
5yr CAGR Net Profit
|
0.08 % | 16.28 % | 33.73 % |
|
5yr Average Return on Assets
|
4.12 % | 17.7 % | 11.07 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
47.68 % | 70.56 % | 49.56 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
-3.0 % | 1.68 % | 0.76 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
5.97 % | 0.87 % | -4.64 % |
|
Jubilant Pharmova
|
Caplin Point Lab
|
Natco Pharma
|
|---|